artco-shutterstock-com
Artco / Shutterstock.com
27 September 2016Americas

Glenmark partners with Particle Sciences in Abraxane generic deal

India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
31 January 2018   Biopharmaceutical company Celgene has reached an agreement with Actavis that will terminate pending patent litigation over Abraxane.

More on this story

Americas
31 January 2018   Biopharmaceutical company Celgene has reached an agreement with Actavis that will terminate pending patent litigation over Abraxane.

More on this story

Americas
31 January 2018   Biopharmaceutical company Celgene has reached an agreement with Actavis that will terminate pending patent litigation over Abraxane.